Potential Nephroprotective Effect of Kaempferol: Biosynthesis, Mechanisms of Action, and Clinical Prospects

Maulana Yusuf Alkandahri1, Asman Sadino2, Barolym Tri Pamungkas3

  • 1Department of Pharmacology and Clinical Pharmacy Faculty of Pharmacy Universitas Buana Perjuangan Karawang, Karawang, West Java, Indonesia.

Insights

Kaempferol, a natural polyphenol, shows promise as a nephroprotective agent against kidney injury. This study reviews its protective effects, mechanisms, and potential for treating kidney diseases.

Area of Science:

  • Nephrology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Kidney injury can lead to glomerulosclerosis, fibrosis, and failure.
  • Current treatments for kidney injury are limited and can have adverse effects.
  • Natural compounds are being explored as alternative therapeutic strategies for kidney diseases.

Purpose of the Study:

  • To review the nephroprotective effects of kaempferol.
  • To explore its molecular mechanisms of action.
  • To discuss its biosynthesis pathways and clinical prospects.

Main Methods:

  • Literature review of studies on kaempferol and kidney injury.
  • Analysis of kaempferol's effects in various nephrotoxicity models.
  • Examination of its impact on physiological pathways.

Main Results:

  • Kaempferol demonstrates nephroprotective potential in models of kidney injury.
  • It exhibits beneficial effects on pathways involved in CPL-induced kidney injury, DOX, LPO, ROS, RCC, and diabetic nephropathy.
  • The compound shows promise for kidney protection and regeneration.

Conclusions:

  • Kaempferol is a promising natural compound for nephroprotection.
  • Further research into its mechanisms and clinical application is warranted.
  • It represents a potential therapeutic strategy for managing kidney diseases.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
469
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
506
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
148